NEW YORK (GenomeWeb) – US Food and Drug Administration Commissioner Scott Gottlieb aims to position the FDA as a facilitator of laboratory test innovation, as agencies and legislators craft a long-term solution for regulation of laboratory-developed tests, he said during a presentation at the American Clinical Laboratory Association conference in Washington DC on Tuesday.

"We have a unique opportunity to set reform and innovate as we consider the right mold for the FDA with respect to laboratory-developed tests," Gottlieb said.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

Already a 360Dx Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.